Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1851]

Targeted therapies associated with increased risk for and incidence of...

Dr James Martin - Cleveland Clinic, Cleveland, USA

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer ( Dr James Martin - Cleveland Clinic, Cleveland, USA )

The use of IORT at L'Hospitalet de Llobregat

Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain

The use of IORT at L'Hospitalet de Llobregat ( Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain )

Understanding intraoperative radiation therapy for early stage breast cancer

Dr Jana Fox - Montefiore Medical Center, New York,USA

Understanding intraoperative radiation therapy for early stage breast cancer ( Dr Jana Fox - Montefiore Medical Center, New York,USA )

The use of IORT at Montefiore Medical Center

Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York...

The use of IORT at Montefiore Medical Center ( Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York, USA )

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC...

Dr Nan Chen - The University of Chicago, Chicago, USA

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than from TC ( Dr Nan Chen - The University of Chicago, Chicago, USA )

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not...

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not impact overall survival ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in...

Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron...

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in high-risk HR-positive/HER2-negative eBC ( Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Olaparib after chemotherapy continues to meaningfully improveme efficacy in...

Dr Judy Garber - Dana-Farber Cancer Institute, Boston, USA

Olaparib after chemotherapy continues to meaningfully improveme efficacy in gBRCApv and high-risk, HER2-negative primary BC ( Dr Judy Garber - Dana-Farber Cancer Institute, Boston, USA )

Immediate breast surgery versus deferral of surgery in women aged 70+ years...

Prof Robert Hills - University of Oxford, Oxford, United Kingdom

Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer ( Prof Robert Hills - University of Oxford, Oxford, United Kingdom )

Breast conserving surgery and IORT can manage locally recurrent breast cancer

Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA

Breast conserving surgery and IORT can manage locally recurrent breast cancer ( Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA )

Addressing Breast Cancer Disparities in Africa

Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche...

Addressing Breast Cancer Disparities in Africa ( Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland )

Recommendations and guidance for people living with and beyond breast cancer...

Dr Helen Croker - World Cancer Research Fund International, London, UK

Recommendations and guidance for people living with and beyond breast cancer and colorectal cancer ( Dr Helen Croker - World Cancer Research Fund International, London, UK )

More from ecancer